| 米非司酮联合桂枝茯苓胶囊治疗子宫肌瘤疗效观察 |
| |
| 引用本文： | 伍艳芳,何凌.米非司酮联合桂枝茯苓胶囊治疗子宫肌瘤疗效观察[J].现代生物医学进展,2011,11(16):3146-3148. |
| |
| 作者姓名： | 伍艳芳 何凌 |
| |
| 作者单位： | 1. 湖南永州市第三人民医院 湖南永州 425000；中南大学湘雅二医院 湖南长沙 410011
2. 中南大学湘雅二医院 湖南长沙 410011 |
| |
| 摘 要： | 目的:探讨米非司酮联合桂枝茯苓胶囊应用于子宫肌瘤治疗的可行性及安全性。方法:76例子宫肌瘤患者随机分为两组,对照组予以米非司酮单独治疗,治疗组加入桂枝茯苓胶囊联合治疗,完成治疗后观察疗效。结果:治疗组总有效率(84.2%)显著高于对照组总有效率(71.1%),组间差异有统计学意义(P<0.05);通过降低患者血生殖激素水平及改变血液流变学情况,两种治疗方法最终有效缩小子宫肌瘤体积,显著改善患者月经量增多、经期延长和贫血症状,且治疗组疗效优于对照组(P<0.05)。结论:米非司酮联合桂枝茯苓胶囊可协同治疗子宫肌瘤,效果较好,且安全性较高。
|
| 关 键 词： | 子宫肌瘤 米非司酮 桂枝茯苓胶囊 |
Clinical Observation of Mifepristone Combined with Guizhifuling Capsule in Treating Hysteromyoma |
| |
| WU Yan-fang,HE Ling.Clinical Observation of Mifepristone Combined with Guizhifuling Capsule in Treating Hysteromyoma[J].Progress in Modern Biomedicine,2011,11(16):3146-3148. |
| |
| Authors: | WU Yan-fang HE Ling |
| |
| Institution: | WU Yan-fang~(1,2),HE Ling~2 (1 The Third People s Hospital of Yongzhou city,Yongzhou,425000,China,2 Department of gynaecology and obstetrics of the second Xiangya Hospita,Central South University,Changsha 410011,China) |
| |
| Abstract: | Objective:To explore the feasibility of mifepristone combined with Guizhifuling capsule in treatment for hysteromyoma.Methods:200 cases of hysteromyoma patients were randomly divided into treatment group and control group,the control group were treated with mifepristone,and the treated group with mifepristone plus Guizhifuling capsule.The clinical effect was evaluated after the treatment.Results:The total effective rate in the treatment group was 84.2%,significantly higher than the control group 71.1% (P<0.... |
| |
| Keywords: | Hysteromyoma Mifepristone Guizhifuling capsule |
| 本文献已被 CNKI 万方数据 等数据库收录！ |
|
